Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Febrile Encephalopathy (Phase 1)
Antigens, CD19 (Phase 1/Phase 2)
Arthritis, Rheumatoid (Phase 1)
Automobiles (Phase 2)
Blood Transfusion (Phase 1/Phase 2)
Bone Marrow Transplantation (Phase 2)
Burkitt Lymphoma (Phase 3)
Colorectal Neoplasms (Early Phase 1)
Dermatomyositis (Phase 1)
Drugs, Investigational (Phase 1/Phase 2)
Electroconvulsive Therapy (Phase 1)
Endoscopy (Phase 1)
Hematologic Neoplasms (Phase 1)
Hodgkin Disease (Phase 2)
Kidney Failure, Chronic (Phase 1)
Kidney Transplantation (Phase 1)
Leukemia (Phase 1/Phase 2)
Leukemia, B-Cell (Phase 2/Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2/Phase 3)
Leukemia, Prolymphocytic (Phase 1)
Leukemia, Prolymphocytic, B-Cell (Phase 1/Phase 2)
Lupus Erythematosus, Systemic (Phase 1/Phase 2)
Lupus Nephritis (Phase 1/Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 4)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 2/Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Chronic Progressive (Phase 1)
Myasthenia Gravis (Phase 1)
Neoplasms (Phase 1/Phase 2)
Neuromyelitis Optica (Phase 1)
Only Child (Early Phase 1)
Pancreatic Neoplasms (Phase 1)
Pediatrics (Phase 2)
Pharmacological and Toxicological Phenomena (Phase 1/Phase 2)
POEMS Syndrome (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2/Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Early Phase 1)
Recurrence (Phase 1/Phase 2)
Renal Insufficiency (Phase 1)
Risk Factors (Phase 2)
Scleroderma, Systemic (Phase 1)
Sjogren's Syndrome (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue